Cytokine-induced changes in mood and behaviour: implications for ???depression due to a general medical condition???, immunotherapy and antidepressive treatment
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Abstract
Several lines of evidence indicate that cytokine-mediated communication pathways between the immune system and the brain are involved in the pathophysiology of depression: (1) . Depression is highly prevalent in various medical conditions, including infectious, autoimmune and neurodegenerative diseases. This clinical association cannot be attributed solely to psychological distress, and it probably reflects direct activation of illness-induced physiological processes. (2). Experiments in humans and in animals demonstrate that exposure to cytokines induces depressive-like mood and behavioural alterations. (3). Cytokine immunotherapy in cancer and hepatitis patients elicits a major depressive episode in a large percentage of the patients. (4). Several types of depression that are not directly associated with a physical disease (e.g. major depression, melancholia, dysthymia) were also associated with cytokine hypersecretion. (5). Antidepressant drugs possess anti-inflammatory characteristics, which may partly account for their therapeutic effect. Congruently, antidepressants were found to reverse cytokine-induced major depression in humans and depressive-like behaviours in animals. (6). Cytokines affect brain systems that were implicated in the aetiology of depression, including the hypothalamus-pituitary-adrenal axis and monoaminergic systems. These conclusions strongly suggest that during medical conditions elevated levels of cytokines directly contribute to the induction of depression. Therefore, illness-associated depression should not be underestimated (in terms of prevalence and severity), and should be treated with antidepressant drugs, which may act on the specific physiological mechanisms of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depression is highly prevalent in infectious, autoimmune and neurodegenerative diseases, and this co-morbidity cannot be attributed only to the psychological distress of the starting disease”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Pollak and Yirmiya, 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Causal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566 · cited 1×
“Stress has been suggested as an important risk factor for depression (Kendler et al., 1999) .”
BackgroundThe Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · cited 2×
“This has been implicated in the aetiology of depression (Holsboer, 2000; Plotsky et al., 1998).”
BackgroundImmune-neuro-endocrine interactions: facts and hypotheses.
BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564
Maier, S. F., & Watkins, L. R. (1998) · Psychological Review · doi:10.1037/0033-295x.105.1.83 · Cited by 1,130 · cited 1×
“Brain cytokines produce alterations in several neurotransmitter, neuroendocrine and behavioural systems (Besedovsky and Del Rey, 1996; Maier and Watkins, 1998).”
BackgroundParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120 · cited 2×
“Using a double-blind, placebo-controlled design, patients were pretreated with the antidepressant paroxetine or placebo for 2 wk prior to the initiation of chronic administration of high-dose interferon therapy for malignant melanoma (Musselman et al., 2001).”
MethodEvidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003 · cited 13×
“Similarly, the antidepressant rolipram was found to suppress TNF-a and also, to a lesser extent, IFN-c secretion by human and rat autoreactive T cells (Sommer et al., 1995).”
BackgroundInfluentialThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 2×
“Smith AP, Thomas M, Brockman P, Kent J, Nicholson KG (1993). Effect of influenza B virus infection on human”
BackgroundCytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862 · cited 1×
“In animal models, these behavioural changes include anhedonia (a reduced capacity toexperiencepleasure), reflectedbyreducedpreference for sweet solutions, decreased intracranial self stimulation and suppressed libido and sexual behaviour, as well as anorexia and body weight loss, hypersomnia, psychomotor retardation,…”
BackgroundPSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70006-x · Cited by 672 · cited 1×
“Activation of the hypothalamic–pituitary–adrenal (HPA) axis This has been implicated in the aetiology of depression (Holsboer, 2000; Plotsky et al., 1998).”
BackgroundPrevalence of Depression in Adults With Diabetes: An epidemiological evaluation
Gavard, J. A., Lustman, P. J., & Clouse, R. E. (1993) · Diabetes Care · doi:10.2337/diacare.16.8.1167 · Cited by 622 · cited 1×
“diabetes mellitus, rheumatoid arthritis, systemic lupus erythematosus, and particularly,multiple sclerosis (Gavard et al., 1993; Hutchinson et al., 1996; Pincus et al., 1996; Schiffer and Babigian, 1984; Schubert and Foliart, 1993).”
BackgroundMajor Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617 · cited 12×
“Similarly, the antidepressant rolipram was found to suppress TNF-a and also, to a lesser extent, IFN-c secretion by human and rat autoreactive T cells (Sommer et al., 1995).”
BackgroundMethodInfluentialEndotoxin produces a depressive-like episode in rats
Yirmiya, R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01415-2 · Cited by 604 · cited 2×
“…antidepressants from several groups (i.e. imipramine, desipramine, fluoxetine and tianeptine) attenuated LPS-induced sickness behaviour, as well as some of the physiological and neuroendocrine effects of LPS in rats (Castanon et al., 2001; Shen et al., 1999; Yirmiya, 1996; Yirmiya et al., 2001).”
BackgroundSelf-citationStahl, S. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0103 · Cited by 489
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482 · cited 1×
“(1993) and later by other researchers (Connor and Leonard, 1998; Dantzer et al., 1999; Leonard, 2001; Maes, 1995, 1999; Raison and Miller, 2001; Yirmiya, 1997, 2000; Yirmiya et al., 1999, 2000) Address for correspondence: Dr R.”
BackgroundBonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437 · cited 1×
“Finally, patients receiving immunotherapy showed reduced levels of tryptophan and 5-HT (Bonaccorso et al., 2002; Capuron et al., 2001b).”
BackgroundDepression in the medically ill: an overview
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.696 · Cited by 435
Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review
Dieperink, E., Willenbring, M., & Ho, S. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.867 · Cited by 422 · cited 1×
“Infectious illnesses, such as influenza, gastroenteritis, hepatitis C, HIV and Epstein–Barr virus, are all associated with a range of depressive symptoms, includingdepressedmood, fatigue, psychomotor retardation, anorexia, as well as attention and memory impairments (Capuron et al., 1999; Dieperink et al., 2000; Maj,…”
BackgroundMonoamine dysfunction and the pathophysiology and treatment of depression.
Charney, D. S. (1998) · PubMed · Cited by 404
Dantzer, R., Konsman, J.-P., Bluthé, R.-M., & Kelley, K. W. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00220-4 · Cited by 400 · cited 1×
“Studies over the last decade revealed several humoral and neural communication pathways between the immune system and the brain (Dantzer et al., 2000; Watkins and Maier, 1999).”
BackgroundMaes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357 · cited 2×
“Seven antidepressant drugs [2 tricyclic, 2 selective serotonin (5-HT) reuptake inhibitors (SSRIs), a 5-HT–noradrenaline reuptake inhibitor, a heterocyclic and the immediate precursor of 5-HT] have been found to suppress the IFN-c/IL-10 production ratio in diluted whole-blood samples of treatment-resistant depression p…”
BackgroundMethodCole, M. G., Bellavance, F., & Mansour, A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1182 · Cited by 350 · cited 1×
“3–53%, depending on different diagnostic criteria (Benazzi, 2000; Cole et al., 1999).”
BackgroundThe antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
Sommer, N., Löschmann, P.-A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., et al. (1995) · Nature Medicine · doi:10.1038/nm0395-244 · Cited by 345 · cited 2×
“Similarly, the antidepressant rolipram was found to suppress TNF-a and also, to a lesser extent, IFN-c secretion by human and rat autoreactive T cells (Sommer et al., 1995).”
BackgroundKubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343 · cited 3×
“Seven antidepressant drugs [2 tricyclic, 2 selective serotonin (5-HT) reuptake inhibitors (SSRIs), a 5-HT–noradrenaline reuptake inhibitor, a heterocyclic and the immediate precursor of 5-HT] have been found to suppress the IFN-c/IL-10 production ratio in diluted whole-blood samples of treatment-resistant depression p…”
BackgroundMethodThe immune system, depression and the action of antidepressants
Leonard, B. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00155-5 · Cited by 333 · cited 1×
“(1993) and later by other researchers (Connor and Leonard, 1998; Dantzer et al., 1999; Leonard, 2001; Maes, 1995, 1999; Raison and Miller, 2001; Yirmiya, 1997, 2000; Yirmiya et al., 1999, 2000) Address for correspondence: Dr R.”
BackgroundHaack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
Xia, Z., Depierre, J. W., & Nässberger, L. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00111-7 · Cited by 318 · cited 2×
“Tricyclic antidepressants (TCAs) were found to induce apoptosis (Xia et al., 1997) and to inhibit spontaneous secretion of IL-2 and IFN-c from T cells, as well as spontaneous and LPS-induced secretion of IL-1, IL-6 and TNF-a from monocytes (Xia et al., 1996).”
BackgroundEffects of Cytokines on Cerebral Neurotransmission: Comparison with the Effects of Stress
Dunn, A. J., Wang, J., & Ando, T. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_8 · Cited by 316 · cited 1×
“…of IL-1b, or elevation of endogenous pro-inflammatory cytokine levels by immune challenges such as LPS, produce an increase in the turnover and extracellular concentrations of norepinephrine and 5-HT or their metabolites, in several brain areas (Dunn et al., 1999; Linthorst and Reul, 1998).”
BackgroundMood and cognitive side effects of interferon-alpha therapy.
Valentine, A. D., Meyers, C. A., Kling, M. A., Richelson, E., & Hauser, P. (1998) · PubMed · Cited by 312
Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine
SŁUŻEWSKA, A., RYBAKOWSKI, J. K., LACIAK, M., MACKIEWICZ, A., SOBIESKA, M., & WIKTOROWICV, K. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32372.x · Cited by 306
Mikova, O., Yakimova, R., Bosmans, E., Kenis, G., & Maes, M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00081-5 · Cited by 305 · cited 12×
“Similarly, the antidepressant rolipram was found to suppress TNF-a and also, to a lesser extent, IFN-c secretion by human and rat autoreactive T cells (Sommer et al., 1995).”
BackgroundInfluentialBehavioral Effects of Cytokines
Larson, S. J., & Dunn, A. J. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0643 · Cited by 296 · cited 1×
“In animal models, these behavioural changes include anhedonia (a reduced capacity toexperiencepleasure), reflectedbyreducedpreference for sweet solutions, decreased intracranial self stimulation and suppressed libido and sexual behaviour, as well as anorexia and body weight loss, hypersomnia, psychomotor retardation,…”
BackgroundCapuron, L., Ravaud, A., & Dantzer, R. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2143 · Cited by 294 · cited 2×
“Administration of cytokines (IL-2, IFN-a or TNF-a) causes influenza-like and depressive symptoms (Capuron et al., 2000; Meyers, 1999; Valentine et al., 1998).”
BackgroundIllness, Cytokines, and Depression
YIRMIYA, R., POLLAK, Y., MORAG, M., REICHENBERG, A., BARAK, O., AVITSUR, R., SHAVIT, Y., OVADIA, H., WEIDENFELD, J., MORAG, A., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05412.x · Cited by 284 · cited 1×
“To examine the effects of antidepressant treatment on serotonergic neurotransmission, we recently tested the effects of chronic treatment with the TCA clomipramine on LPS-induced secretion of brain 5-HT (Yirmiya et al., 2000).”
MethodSelf-citationImplications of immune-to-brain communication for sickness and pain
Watkins, L. R., & Maier, S. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7710 · Cited by 250 · cited 1×
“Studies over the last decade revealed several humoral and neural communication pathways between the immune system and the brain (Dantzer et al., 2000; Watkins and Maier, 1999).”
BackgroundLong-term medical conditions and major depression in a Canadian population study at waves 1 and 2
Patten, S. B. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00186-5 · Cited by 239
Bonaccorso, S., Puzella, A., Marino, V., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Levrero, M., Egyed, B., Bosmans, E., et al. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00315-8 · Cited by 236 · cited 1×
“…of IL-6, IL-8 and IL-10 and with decreased levels of serum dipeptidyl peptidase IV (a membranebound serine protease, which catalyses the cleavage of some cytokines and neuroactive peptides that modulate T-cell activity) (Bonaccorso et al., 2001 ; Capuron et al., 2001a; Maes et al., 2001a,b).”
BackgroundCytokines, “depression due to a general medical condition”, and antidepressant drugs
Yirmiya, R., Weidenfeld, J., Pollak, Y., Morag, M., Morag, A., Avitsur, R., Barak, O., Reichenberg, A., Cohen, E., Shavit, Y., et al. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_16 · Cited by 208
Self-citationFassbender, K., Schmidt, R., Mößner, R., Kischka, U., Kühnen, J., Schwartz, A., & Hennerici, M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.66 · Cited by 204 · cited 1×
“Importantly, several studies have revealed that immune deregulation and inflammatory activity preceded and coincidedwithmultiplesclerosis-associateddepression (Fassbender et al., 1998; Foley et al., 1992; Mohr et al., 2001).”
BackgroundCapuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., & Neveu, P. J. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00030-0 · Cited by 201
Antidepressant pharmacotherapy of depression associated with multiple sclerosis
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.11.1493 · Cited by 200 · cited 1×
“Both TCAs and SSRIs are of proven value in treating depression associated with a wide range of conditions (Gottfries, 1997; Lauritzen et al., 1994; Rabkin et al., 1994; Schiffer and Wineman, 1990; Van Heeringen and Zivkov, 1996).”
BackgroundMohr, D. C., Goodkin, D. E., Islar, J., Hauser, S. L., & Genain, C. P. (2001) · Archives of Neurology · doi:10.1001/archneur.58.7.1081 · Cited by 190 · cited 3×
“Importantly, several studies have revealed that immune deregulation and inflammatory activity preceded and coincidedwithmultiplesclerosis-associateddepression (Fassbender et al., 1998; Foley et al., 1992; Mohr et al., 2001).”
BackgroundNEUROPSYCHIATRIC CONSEQUENCES OF STROKE
Robinson, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.217 · Cited by 187
Schiffer, R. B. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050210065016 · Cited by 183
Increased Depression in Multiple Sclerosis Patients
Schubert, D. S. P., & Foliart, R. H. (1993) · Psychosomatics · doi:10.1016/s0033-3182(93)71902-7 · Cited by 177 · cited 1×
“diabetes mellitus, rheumatoid arthritis, systemic lupus erythematosus, and particularly,multiple sclerosis (Gavard et al., 1993; Hutchinson et al., 1996; Pincus et al., 1996; Schiffer and Babigian, 1984; Schubert and Foliart, 1993).”
BackgroundInflammatory markers in major depression and melancholia.
Rothermundt, M., Arolt, V., Peters, M., Gutbrodt, H., Fenker, J., Kersting, A., & Kirchner, H. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00157-9 · Cited by 174
Cytokines and depression: fortuitous or causative association?
Dantzer, R., Wollman, E., Vitkovic, L., & Yirmiya, R. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000572 · Cited by 174 · cited 1×
“(1993) and later by other researchers (Connor and Leonard, 1998; Dantzer et al., 1999; Leonard, 2001; Maes, 1995, 1999; Raison and Miller, 2001; Yirmiya, 1997, 2000; Yirmiya et al., 1999, 2000) Address for correspondence: Dr R.”
BackgroundSelf-citationPREVALENCE OF SELF-REPORTED DEPRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
PINCUS, T., GRIFFITH, J., PEARCE, S., & ISENBERG, D. (1996) · Rheumatology · doi:10.1093/rheumatology/35.9.879 · Cited by 170
First isolates of infectious human Borna disease virus from patients with mood disorders.
Bode, L., Dürrwald, R., Rantam, F. A., Ferszt, R., & Ludwig, H. (1996) · PubMed · Cited by 165
Morikawa, O., Sakai, N., Obara, H., & Saito, N. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00187-3 · Cited by 160 · cited 1×
“Furthermore, IL-1, TNF-a and IFN-c were all found to up-regulate the 5-HT transporter (5-HTT), whereas IL-4 was found to downregulate the 5-HTT (Morikawa et al., 1998; Mossner et al., 1998, 2001; Ramamoorthy et al., 1995).”
BackgroundDifferent immune patterns in melancholic and non-melancholic major depression
Rothermundt, M., Arolt, V., Fenker, J., Gutbrodt, H., Peters, M., & Kirchner, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170058 · Cited by 159
Regulation of the Human Serotonin Transporter by Interleukin-1β
Ramamoorthy, S., Ramamoorthy, J. D., Prasad, P. D., Bhat, G. K., Mahesh, V. B., Leibach, F. H., & Ganapathy, V. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2659 · Cited by 156 · cited 1×
“Furthermore, IL-1, TNF-a and IFN-c were all found to up-regulate the 5-HT transporter (5-HTT), whereas IL-4 was found to downregulate the 5-HTT (Morikawa et al., 1998; Mossner et al., 1998, 2001; Ramamoorthy et al., 1995).”
BackgroundPharmacological Treatment of Depression in Cancer Patients: A Placebo-Controlled Study of Mianserin
Van Heeringen, K., & Zivkov, M. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.440 · Cited by 150
Yaron, I., Shirazi, I., Judovich, R., Levartovsky, D., Caspi, D., & Yaron, M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199912)42:12<2561::aid-anr8>3.0.co;2-u · Cited by 147 · cited 2×
“A recent in-vitro study has shown that both TCAs and SSRIs attenuated cytokine-induced PGE2 and nitric oxide production by inflammatory cells from synovial tissue (Yaron et al., 1999).”
BackgroundShen, Y., Connor, T. J., Nolan, Y. M., Kelly, J. P., & Leonard, B. E. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00430-0 · Cited by 146 · cited 2×
“imipramine, desipramine, fluoxetine and tianeptine) attenuated LPS-induced sickness behaviour, as well as some of the physiological and neuroendocrine effects of LPS in rats (Castanon et al., 2001; Shen et al., 1999; Yirmiya, 1996; Yirmiya et al., 2001).”
BackgroundMößner, R., Heils, A., Stöber, G., Okladnova, O., Daniel, S., & Lesch, K. P. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00026-6 · Cited by 137 · cited 1×
“Furthermore, IL-1, TNF-a and IFN-c were all found to up-regulate the 5-HT transporter (5-HTT), whereas IL-4 was found to downregulate the 5-HTT (Morikawa et al., 1998; Mossner et al., 1998, 2001; Ramamoorthy et al., 1995).”
BackgroundCastanon, N., Bluthé, R.-M., & Dantzer, R. (2001) · Psychopharmacology · doi:10.1007/s002130000595 · Cited by 136 · cited 2×
“imipramine, desipramine, fluoxetine and tianeptine) attenuated LPS-induced sickness behaviour, as well as some of the physiological and neuroendocrine effects of LPS in rats (Castanon et al., 2001; Shen et al., 1999; Yirmiya, 1996; Yirmiya et al., 2001).”
BackgroundDepressive Symptoms and Mortality in Older Mexican Americans
Black, S. A., & Markides, K. S. (1999) · Annals of Epidemiology · doi:10.1016/s1047-2797(98)00025-8 · Cited by 127 · cited 1×
“, 1999)] and is associated with poorer prognosis (Black and Markides, 1999).”
BackgroundKubera, M., Kenis, G., Bosmans, E., Zieba, A., Dudek, D., Nowak, G., & Maes, M. H. J. (2000) · PubMed · Cited by 127
Cytokine production in major depressed patients before and after clomipramine treatment
Weizman, R., Laor, N., Podliszewski, E., Notti, I., Djaldetti, M., & Bessler, H. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91166-5 · Cited by 126 · cited 1×
“Moreover, in a study of depressed patients who exhibited immune suppression before treatment, the TCA clomipramine increased the production of IL-1b, IL-2, and IL-3 (Weizman et al., 1994).”
BackgroundMaes, M. H. J., Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., & Meltzer, H. Y. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000872 · Cited by 125 · cited 2×
“…of IL-6, IL-8 and IL-10 and with decreased levels of serum dipeptidyl peptidase IV (a membranebound serine protease, which catalyses the cleavage of some cytokines and neuroactive peptides that modulate T-cell activity) (Bonaccorso et al., 2001 ; Capuron et al., 2001a; Maes et al., 2001a,b).”
BackgroundMaes, M. H. J., Bosmans, E., & Meltzer, H. Y. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02193091 · Cited by 123
Major depressive disorder is associated with elevated monocyte counts
Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., & Kirchner, H. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09849.x · Cited by 123 · cited 5×
“Tricyclic antidepressants (TCAs) were found to induce apoptosis (Xia et al., 1997) and to inhibit spontaneous secretion of IL-2 and IFN-c from T cells, as well as spontaneous and LPS-induced secretion of IL-1, IL-6 and TNF-a from monocytes (Xia et al., 1996).”
BackgroundInfluentialKonan, K. V., & Taylor, M. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19140 · Cited by 116 · cited 2×
“IDO is the first rate-limiting enzyme of the catabolism pathway of the 5-HT precursor tryptophan , and its induction by cytokines such as IFN-c enhances the catabolism of tryptophan (Konan and Taylor, 1996).”
BackgroundThe neuroimmunology of stress and depression
Raison, C. L., & Miller, A. H. (2001) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2001.0060277 · Cited by 116
Lycke, E., Norrby, R., & Roos, B.-E. (1974) · British Journal of Psychiatry · doi:10.1192/bjp.124.3.273 · Cited by 106 · cited 2×
“This hypothesis is supported by studies reporting increased antibody titres to several viruses, particularly herpes simplex virus (HSV) in patients with major depression (Cappel et al., 1978; Lycke et al., 1974).”
ResultKubera, M., Maes, M., Holan, V., Basta-Kaim, A., Roman, A., & Shani, J. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00182-8 · Cited by 103
Thomas, A. J., Ferrier, I. N., Kalaria, R. N., Woodward, S. A., Ballard, C., Oakley, A., Perry, R. H., & O’Brien, J. T. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1682 · Cited by 102 · cited 1×
“Late-onset depression was associated with elevated levels of intercellular adhesion molecule-1, a marker of ischaemia-induced inflammation (Thomas et al., 2000).”
BackgroundKubera, M., Symbirtsev, A., Basta‐Kaim, A., Borycz, J. A., Roman, A., Papp, M., & Claësson, M. H. (1996) · PubMed · Cited by 99
Mood and cognitive disorders in cancer patients receiving cytokine therapy.
Meyers, C. A. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_5 · Cited by 98 · cited 2×
“Administration of cytokines (IL-2, IFN-a or TNF-a) causes influenza-like and depressive symptoms (Capuron et al., 2000; Meyers, 1999; Valentine et al., 1998).”
BackgroundInterleukin-1β production in dysthymia before and after pharmacotherapy
Anisman, H., Ravindran, A. V., Griffiths, J., & Merali, Z. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00211-5 · Cited by 97 · cited 1×
“On the other hand, antidepressant treatment, though effectively ameliorated depressive symptoms, had no effect on major depression-associated up-regulation of sIL-2R, IL-6, sIL-6R, IL-10 and IL-1Ra and dysthymia-associated up-regulation of IL-1 (Anisman et al., 1999; Kubera et al., 2000c).”
BackgroundIgnatowski, T. A., Noble, B. K., Wright, J. R., Gorfien, J. L., Heffner, R. R., & Spengler, R. N. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00107-0 · Cited by 95 · cited 2×
“These findings were interpreted as reflective of increased protein generation and also increased release or redistribution within the cell (Ignatowski et al., 1997 ; Nickola et al., 2001).”
Brain Neurotransmission during Peripheral Inflammationa
LINTHORST, A. C. E., & REUL, J. M. H. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09558.x · Cited by 88 · cited 1×
“…of IL-1b, or elevation of endogenous pro-inflammatory cytokine levels by immune challenges such as LPS, produce an increase in the turnover and extracellular concentrations of norepinephrine and 5-HT or their metabolites, in several brain areas (Dunn et al., 1999; Linthorst and Reul, 1998).”
BackgroundYirmiya, R. (1997) · Current Opinion in Psychiatry · doi:10.1097/00001504-199711000-00011 · Cited by 88
Self-citationA Prospective Study of Depression and Immune Dysregulation in Multiple Sclerosis
Foley, F. W., Traugott, U., LaRocca, N. G., Smith, C. R., Perlman, K. R., Caruso, L. S., & Scheinberg, L. C. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530270052018 · Cited by 87 · cited 1×
“Importantly, several studies have revealed that immune deregulation and inflammatory activity preceded and coincidedwithmultiplesclerosis-associateddepression (Fassbender et al., 1998; Foley et al., 1992; Mohr et al., 2001).”
BackgroundModulation of serotonin transporter function by interleukin-4
Mößner, R., Daniel, S., Schmitt, A. G., Albert, D., & Lesch, K. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00992-9 · Cited by 86 · cited 1×
“Furthermore, IL-1, TNF-a and IFN-c were all found to up-regulate the 5-HT transporter (5-HTT), whereas IL-4 was found to downregulate the 5-HTT (Morikawa et al., 1998; Mossner et al., 1998, 2001; Ramamoorthy et al., 1995).”
BackgroundMills, T. L. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00361-0 · Cited by 84 · cited 3×
“Self-report studies of geriatric populations revealed that chronic digestive, arthritic, respiratory and heart diseases, migraine headaches, sinusitis and back pain weremore related to depression than cancer, hypertension, diabetes and hearing or vision loss (Lee et al., 2001; Mills, 2001; Patten, 2001).”
BackgroundResultAntibody and cell-mediated immunity to herpes simplex virus in psychotic depression.
Cappel, R., Gregoire, F., Thiry, L. F., & Sprecher, S. (1978) · PubMed · Cited by 84
Depression in medical illness: The role of the immune system
Yirmiya, R. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.173.5.333 · Cited by 81 · cited 1×
“To examine the effects of antidepressant treatment on serotonergic neurotransmission, we recently tested the effects of chronic treatment with the TCA clomipramine on LPS-induced secretion of brain 5-HT (Yirmiya et al., 2000).”
MethodSelf-citationMaes, M. H. J., Meltzer, H. Y., Scharpé, S., Cooreman, W., Uyttenbroeck, W., Suy, E., Vandervorst, C., Calabrese, J. R., Raus, J., & Cosyns, P. R. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90081-q · Cited by 78 · cited 1×
“The involvement of IDO in cytokineinduced depression was first suggested by Maes et al. (1993) and is supported by a study reporting that cancer patients with depression and cachexia exhibited significantly elevated levels of serum neopterin (a marker of endogenous IFN-c), along with decreased 5-HT…”
BackgroundKubera, M., Holáň, V., Mathison, R., & Maes, M. H. J. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00026-3 · Cited by 76
Post-stroke depression: combined treatment with imipramine or desipramine and mianserin
Lauritzen, L., Bendsen, B. B., Vilmar, T., Bendsen, E. B., Lunde, M., & Bech, P. (1994) · Psychopharmacology · doi:10.1007/bf02245452 · Cited by 76
Effect of influenza B virus infection on human performance.
Smith, A. P., Thomas, M., Brockman, P., Kent, J., & Nicholson, K. G. (1993) · BMJ · doi:10.1136/bmj.306.6880.760 · Cited by 67
Immune–inflammatory markers in patients with seasonal affective disorder: effects of light therapy
Leu, S., Shiah, I., Yatham, L. N., Cheu, Y.-M., & Lam, R. W. M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00165-8 · Cited by 67 · cited 4×
“Similarly , successful light therapy did not alter the elevated levels of IL-6 and sIL-2R in patients with seasonal affective disorder (Leu et al., 2001).”
BackgroundInfluentialMAES, M., OMBELET, W., VERKERK, R., BOSMANS, E., & SCHARPÉ, S. (2001) · Psychological Medicine · doi:10.1017/s0033291701004007 · Cited by 67
Dynamic Regulation of Proinflammatory Cytokines
Watkins, L. R., Nguyen, K. T., Lee, J. E., & Maier, S. F. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_10 · Cited by 67 · cited 1×
“Several studies suggest that exposure to stress in both humans and animals results in increased production of pro-inflammatory cytokines (for review see Watkins et al., 1999).”
BackgroundCentral Monoamine Activity following Acute and Repeated Systemic Interleukin-2 Administration
Lacosta, S., Merali, Z., & Anisman, H. (2000) · Neuroimmunomodulation · doi:10.1159/000026457 · Cited by 62 · cited 2×
“repeated IL-2 administration was found to increase 5-HT and norepinephrine turnover (Lacosta et al., 2000).”
BackgroundAssociation of Comorbidity with Depressive Symptoms in Community-Dwelling Older Persons
Lee, Y., Choi, K., & Lee, Y. K. (2001) · Gerontology · doi:10.1159/000052809 · Cited by 61 · cited 1×
“Self-report studies of geriatric populations revealed that chronic digestive, arthritic, respiratory and heart diseases, migraine headaches, sinusitis and back pain weremore related to depression than cancer, hypertension, diabetes and hearing or vision loss (Lee et al., 2001; Mills, 2001; Patten, 2001).”
BackgroundThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90266-2 · Cited by 60
Rabkin, J. G., Wagner, G. J., & Rabkin, R. (1994) · PubMed · Cited by 58
Attentional and mnemonic deficits associated with infectious disease in humans
CAPURON, L., LAMARQUE, D., DANTZER, R., & GOODALL, G. (1999) · Psychological Medicine · doi:10.1017/s0033291798007740 · Cited by 57 · cited 1×
“Infectious illnesses, such as influenza, gastroenteritis, hepatitis C, HIV and Epstein–Barr virus, are all associated with a range of depressive symptoms, includingdepressedmood, fatigue, psychomotor retardation, anorexia, as well as attention and memory impairments (Capuron et al., 1999; Dieperink et al., 2000; Maj,…”
BackgroundEffect of Tryptophan Depletion on Mood in Male and Female Volunteers: A Pilot Study
SMITH, K. A., CLIFFORD, E. M., HOCKNEY, R. A., CLARK, D. M., & COWEN, P. J. (1997) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199703/04)12:2<111::aid-hup846>3.0.co;2-m · Cited by 56
Maes, M. H. J., Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Egyed, B., Dantzer, R., & Neveu, P. J. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00168-8 · Cited by 55 · cited 2×
“…of IL-6, IL-8 and IL-10 and with decreased levels of serum dipeptidyl peptidase IV (a membranebound serine protease, which catalyses the cleavage of some cytokines and neuroactive peptides that modulate T-cell activity) (Bonaccorso et al., 2001 ; Capuron et al., 2001a; Maes et al., 2001a,b).”
BackgroundDepressive Syndromes and Symptoms in Subjects with Human Immunodeficiency Virus (HIV) Infection
Maj, M. (1996) · British Journal of Psychiatry · doi:10.1192/s0007125000298498 · Cited by 51 · cited 1×
“Infectious illnesses, such as influenza, gastroenteritis, hepatitis C, HIV and Epstein–Barr virus, are all associated with a range of depressive symptoms, includingdepressedmood, fatigue, psychomotor retardation, anorexia, as well as attention and memory impairments (Capuron et al., 1999; Dieperink et al., 2000; Maj,…”
BackgroundLandmann, R., Schaub, B., Link, S., & Wacker, H. R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00176-x · Cited by 45 · cited 3×
“chronic moclobemide treatment had no effect on monocytes functions, TNF-a production or IFN-c levels (Landmann et al., 1997).”
BackgroundDunn, A. J., & Swiergiel, A. H. (2001) · Neuroimmunomodulation · doi:10.1159/000049021 · Cited by 43 · cited 1×
“In contrast, treating mice with similar protocols had no effect on LPS-induced reduction in appetitive-hedonic behaviour (Dunn and Swiergiel, 2001).”
BackgroundIs depression associated with immune activation?
Natelson, B. H., Denny, T., Zhou, X. D., LaManca, J. J., Ottenweller, J. E., Tiersky, L., DeLuca, J., & Gause, W. C. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00118-9 · Cited by 37 · cited 2×
“It may be argued that these negative results are attributed to concurrent medication of many of the patients (Natelson et al., 1999) or to limitations in detection of low cytokine (particularly IL-6 and TNF-levels (Haack et al., 1999).”
BackgroundMtabaji, J., Manku, M. S., & Horrobin, D. F. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90161-7 · Cited by 36 · cited 2×
“Over 20 years ago it was suggested that antidepressants might inhibit the synthesis of PGE 2 (Mtabaji et al., 1977).”
BackgroundNickola, T. J., Ignatowski, T. A., Reynolds, J. L., & Spengler, R. N. (2001) · PubMed · Cited by 35
Zaharia, M. D., Ravindran, A. V., Griffiths, J., Merali, Z., & Anisman, H. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00100-7 · Cited by 34 · cited 2×
“, 2001), and that mitogen-stimulated lymphocyte proliferation was reduced to a greater extent among the dysthymic patients (Zaharia et al., 2000).”
BackgroundZhu, J., Bengtsson, B.-O., Mix, E., Thorell, L., Olsson, T. P., & Link, H. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90019-1 · Cited by 32 · cited 2×
“, 1996, 2001b), and inhibited immune activation in rats with experimental allergic neuritis (Zhu et al., 1994).”
BackgroundTricyclic antidepressants induce apoptosis in human T lymphocytes
Xia, Z., Karlsson, H., DePierre, J. W., & Nässberger, L. (1998) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(97)00020-9 · Cited by 32
Recognition and management of depression in the elderly
Gottfries, C. G. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199712007-00006 · Cited by 32
Differences in interleukins’ patterns between dysthymia and major depression
Schlatter, J., Ortuño, F., & Cervera-Enguix, S. (2001) · European Psychiatry · doi:10.1016/s0924-9338(01)00585-5 · Cited by 30 · cited 2×
“…the levels of IL-6 were significantly increased in the two conditions, whereas the levels of IL-1 were increased only in the dysthymic patients (Schlatter et al., 2001), and that mitogen-stimulated lymphocyte proliferation was reduced to a greater extent among the dysthymic patients (Zaharia…”
BackgroundResultCancer cachexia and depressive states: a neuro-endocrine-immunological disease?
Iwagaki, H., HIZUTA, A., Uomoto, M., Takeuchi, Y., Saito, S., & Tanaka, N. (1997) · PubMed · doi:10.18926/amo/30766 · Cited by 28 · cited 2×
“(1993) and is supported by a study reporting that cancer patients with depression and cachexia exhibited significantly elevated levels of serum neopterin (a marker of endogenous IFN-c), along with decreased 5-HT and tryptophan levels (Iwagaki et al., 1997).”
BackgroundResultMorag, M., Yirmiya, R., Lerer, B., & Morag, A. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00012-2 · Cited by 27 · cited 1×
“We have used a double-blind prospective design to investigate the immediate and prolonged psychological and physiological effects of a specific viral infection in humans (Morag et al., 1998).”
MethodSelf-citationANTIDEPRESSANT DRUGS AND EXPERIMENTAL INFLAMMATION
Bianchi, M. (1996) · Pharmacological Research · doi:10.1006/phrs.1996.0032 · Cited by 27 · cited 3×
“Thus, in addition to the ample literature on the anti-inflammatory characteristics of antidepressant drugs (for review see Bianchi and Panerai, 1996 ), more research is needed on the antidepressive effects of anti-inflammatory drugs.”
BackgroundInfluentialMood and experimentally-induced respiratory virus infections and illnesses
Smith, A. P., Tyrrell, D. A. J., Barrow, G. I., Higginsaf, P. G., Willman, J. S., Bull, S., Coyle, K. B., & Trickett, S. (1992) · Psychology & Health · doi:10.1080/08870449208403184 · Cited by 26
Kubera, M., Kenis, G., Bosmans, E., Jaworska-Feil, L., Lasoń, W., Scharpé, S., & Maes, M. H. J. (2000) · PubMed · Cited by 21
Recognition and management of depression in the elderly
Gottfries, C. G., Noltorp, S., & Nørgaard, N. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)87812-2 · Cited by 20
Psychiatric disorders in Systemic Lupus Erythematosus.
Hutchinson, G. A., Neehall, J. E., & SIMEON, D. T. (1996) · PubMed · Cited by 20
Immune Disturbances in Treatment-Resistant Depression: Modulation by Antidepressive Treatments
MAES, M., VANDOOLAEGHE, E., VAN HUNSEL, F., BRIL, T., DEMEDTS, P., WAUTERS, A., & NEELS, H. (1997) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199703/04)12:2<153::aid-hup852>3.0.co;2-n · Cited by 19 · cited 2×
“…treatment with fluoxetine (Sluzewska et al., 1995), the increased monocyte counts in depressed patients were reduced following 6 wk treatment with TCAs (Seidel et al., 1996), and the increased numbers of leucocytes and neutrophils were also reduced by antidepressant treatment (Maes et al., 1997).”
BackgroundLate-life chronic depression: a 399-case study in private practice
Benazzi, F. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200001)15:1<1::aid-gps68>3.0.co;2-7 · Cited by 12
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80580-5 · Cited by 7 · cited 1×
“To further examine the role of cytokines in the psychological alterations that accompany infection and inflammation, we have recently studied the effects of lipopolysaccharides (LPS) on affective and cognitive variables in healthy volunteers (Reichenberg et al., 2001, In Press).”
BackgroundSelf-citationMajor depression, viral reactivation and immune system
Zorzenon, M., Colle, R. D., Vecchio, D., Bertoli, M., Giavedoni, A., Degrassi, A., Lavaroni, S., Aguglia, E., & Botta, G. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)89040-7 · Cited by 6
White, P. D. (1999) · General Hospital Psychiatry · doi:10.1016/s0163-8343(98)00071-1 · Cited by 4 · cited 1×
“In contrast, prospective studies of infectious mononucleosis patients provided no evidence for prolonged depressive episodes (for review see Peter and White, 1999).”
Result
Research works printed but not linked: 5
- Castanon N, Me ´dina C, Morme `de C, Dantzer R (In Press). Chronic treatment with the antidepressant tianeptine attenuates splenic and brain expression of pro-inflammatory cytokines. Brain, Behavior and Immunity.
- Delgado PL (2000). Depression: the case for a monoamine deficiency. Journal of Clinical Psychiatry 61, S7-S11.
- Lestage J, Gaunt D, Pehourcq F, Dantzer R (In Press). Evidence for induction of IDO in the brain in response to peripheral immune stimuli. Brain, Behavior and Immunity.
- Linthorst AC, Reul JM (1998). Brain neurotransmission during peripheral inflammation. Annals of New York Academy of Sciences 840, 139-152.
- Reichenberg A, Schuld A, Kraus T, Haack M, Pollma ¨cher T, Yirmiya R (In Press). Endotoxin-induced anorexia in healthy human volunteers is mediated by cytokine secretion. Psychoneuroendocrinology.
Cited by
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
“Autoimmune disorders including multiple sclerosis, rheumatic disease, asthma, and allergies are also associated with high rates of neuropsychiatric symptoms and depression (Pollak and Yirmiya, 2002).”
BackgroundDepression as a Microglial Disease
Yirmiya, R., Rimmerman, N., & Reshef, R. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.001 · Cited by 944
“The KP was proposed to serve as the switch from acute (sickness-like) effects of inflammatory challenges and stress to the development of depression [4,123,124].”
BackgroundSelf-citationSilverman, M. N., & Sternberg, E. M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06633.x · Cited by 731
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762
Self-citationDiet and depression: Exploring the biological mechanisms of action
Marx, W., Lane, M., Hockey, M., Aslam, H., Berk, M., Walder, K., Borsini, A., Firth, J., Pariante, C. M., Berding, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00925-x · Cited by 685
Metadata
- Authors
- Pollak, Y., & Yirmiya, R.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Corresponding author
- Yirmiya, Raz
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12
- Volume
- 5
- Issue
- 4
- Pages
- 389-399
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2125984173
- Cited by
- 215
- References
- 115
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 3 · 2023: 8 · 2022: 12 · 2021: 8 · 2020: 12 · 2019: 8 · 2018: 10 · 2017: 10 · 2016: 13 · 2015: 16 · 2014: 14 · 2013: 14 · 2012: 11
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hebrew University of Jerusalem
- Israel Science Foundation
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- cytokines, depression, cytokine therapy, hypothalamic-pituitary-adrenal axis, monoaminergic systems, major depressive disorder, cancer patients, hepatitis patients
- MeSH terms
- Affect, Animals, Antidepressive Agents, Behavior, Behavior, Animal, Depressive Disorder, Humans, Hypothalamo-Hypophyseal System, Immune System, Immunotherapy, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.